Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Lyell Immunopharma, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate(4) | Amount of Registration Fee(4) | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Securities Forward | |||||||||||||
| Primary Offering of Securities: | ||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock, $0.0001 par value per share | Rule 456(b) and Rule 457(r) | (1)(2) | (3) | (3) | (4) | (4) | ||||||||||||||||
| Equity | Preferred Stock, $0.0001 par value per share | Rule 456(b) and Rule 457(r) | (1)(2) | (3) | (3) | (4) | (4) | |||||||||||||||||
| Debt | Debt Securities | Rule 456(b) and Rule 457(r) | (1)(2) | (3) | (3) | (4) | (4) | |||||||||||||||||
| Other | Warrants | Rule 456(b) and Rule 457(r) | (1)(2) | (3) | (3) | (4) | (4) | |||||||||||||||||
| Other | Units | Rule 456(b) and Rule 457(r) | (1)(2) | (3) | (3) | (4) | (4) | |||||||||||||||||
| Primary Offering of Common Stock: | ||||||||||||||||||||||||
| Equity | Common Stock, $0.0001 par value per share | Rule 457(o) and Rule 457(r) | (1) | (3) | $200,000,000 | 0.0000927 | $18,540 | |||||||||||||||||
Fees Previously Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||||||||
| Total Offering Amounts | (3) | $200,000,000 | $18,540 | |||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $18,540 | |||||||||||||||||||||||
(1) The securities registered hereunder include such indeterminate number of (a) shares of common stock, (b) shares of preferred stock, (c) debt securities, (d) warrants to purchase common stock, preferred stock or other securities of the registrant, as may be sold from time to time by the registrant. There are also being registered hereunder an indeterminate number of shares of common stock and preferred stock as shall be issuable upon conversion, exchange or exercise of any securities that provide for such issuance.
(2) Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any stock splits, stock dividend or similar transaction.
(3) The proposed maximum per security and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities.
(4) In accordance with Rules 456(b) and 457(r) under the Securities Act, the registrant is deferring payment of the entire registration fee other than the registration fee due in connection with $200,000,000 of shares of common stock that may be issued and sold from time to time under the equity distribution agreement prospectus supplement included herein. Any subsequent registration fees will be paid on a pay-as-you-go basis.
(5) An indeterminate number of shares of common stock is being registered as may from time to time be offered hereunder at indeterminate prices.
